Dublin, Sept. 16, 2022 (GLOBE NEWSWIRE) -- The "Thailand Medical Device Market Outlook to 2026F" report has been added to ResearchAndMarkets.com's offering.
The Thailand medical device market is expected to grow at a double digit CAGR from 2021-2026F, with imports contributing majority of the market revenues.
The creation of a world-class healthcare sector is a top priority for the Thailand and the healthcare sector is expected to advance and expand significantly in the next few years which will support the growth of Medical Device Market in the country.
Aging population along with increase in number of hospitals and clinics, increase in total healthcare expenditure by the government and increase in medical tourism in the country are going to impact the demand for medical devices in the positive manner.
Thailand Medical Device Market Overview and Size:
Thailand recorded the 5.0% population growth rate over the last 7 years, with highest population concentrated in Bangkok. Majority of the healthcare facilities are concentrated in Bangkok and other central regions of the Thailand. The country has a comprehensive, government-funded health service and a rapidly developing private health sector, which is one of the major pillar of the industry.
Universal Coverage Card is the most used insurance in Thailand. Social Security (SSS) is followed by Civil Servant Medical Benefit Scheme (CSMBS). Private insurance contributed 7.33% to the total insurances in Thailand. Diabetes and lung cancer causes most death in Indonesia.
Competitive Landscape in the Thailand Medical Devices Market:
The competition scenario in Thailand medical devices market is highly concentrated for Orthopedic Product and Diagnostics imaging market and moderately concentrated due to the presence of large number of international companies and local distributors leading to dilution of market share.
The international companies distribute their products through authorized distributors located across the country. GE, Siemens, Philips, Canon and Fujifilm are the major companies operating in the Thailand Medical Device market.
Meditop, Mind medical and R.X. Company are few top distributors in Thailand. The major competitive parameters include product portfolio, price, and after sales and warranty and technology
Thailand Medical Device Market Segmentation:
Imports have accounted for majority of the revenue share in Thailand Medical Device Market in 2020. The imports are largely related to more sophisticated medical and surgical instruments and infrastructure.
Distributor Mediated Sales have accounted for majority of the revenue in Thailand Medical Device Market in 2021. Majority of the international companies hire distributors in Thailand through which it sells the medical devices to hospitals, diagnostic laboratories and other non-residential customers.
Medical Consumables have accounted for the largest share of of the revenue in Thailand Medical Devices market in 2021, followed by Diagnostic Reagents and cardiac devices.
Syringes, Needles and Catheters, Surgical Gloves and Intravenous Admin Sets contributed more than 50.0% revenue in 2021. The COVID-19 outbreak and increasing hospital admissions across the country have significantly increased the demand for medical disposables.
CT Scans contributed the highest revenue share in 2021 followed by X Ray Based Products, Ultrasound and MRI. The CT Scan segment witnessed the fastest growth since they are one of the primary diagnostic tools for COVID-19 patients.
In Thailand the production of medical devices are exported to other parts of the world which contributes 70% of the overall production.
Thailand's key export markets are the United States, followed by Japan, the Netherlands, and Germany. Most of the manufacturers and exporters in Thailand are foreign-owned companies that export the items back to their home countries, e.g. Japan, the United States and France.
Oxygen Concentrators contributed highest revenue share in 2020. The Thailand population has high risk of exposures to occupational and environmental factors that lead to illnesses such as asthma, chronic bronchitis and emphysema.
Hospital Beds with Mechanical Fittings and Dentists' Chairs contributed highest revenue share in 2021. Increasing number of hospitals and lifestyle diseases along with operations on morbidly obese patients is increasing by more than 18.6K cases a year and Increasing incidences of chronic diseases and a rise in geriatric population is driving growth.
Implants and Artificial Body parts have accounted for largest revenue share in the Thailand medical devices market in 2021. Frequent road accidents (~About 20,000 people die in road accidents each year, or about 56 deaths a day) and injuries driving the auxiliary devices market.
Dental Appliances contributed the highest revenue and contributed 20.0% of the overall revenue in 2021. Oral implant surgery, products for sensitive teeth and gum are some of the major areas in dental care which led to demand of these equipment's.
Hospitals along with Clinics and Diagnostic Lab Centers contribute majority of the market revenue in Thailand Medical Devices Market in 2021. Consumer and provider attitudes toward telehealth have improved since the post-COVID-19 era. Virtual healthcare and business models are evolving, moving from purely "virtual urgent care" to a range of services enabling integration of telehealth with other virtual health solutions, and hybrid virtual/in-person care models.
Regulatory Framework in Thailand Medical Device Market
Government Support Towards Medical Device Sector
Incentives Given By Thailand Board of Investment
Regulatory Process for Medical Device
Market Opportunity and Analyst Recommendation
Market Opportunity Analysis for Medical Devices in the Thailand
Recommendation for Medical Device Manufacturers
Case Study of China and Ireland Medical Device Industry
Market Attractiveness for Medical Device Companies
Market Entry Strategy in Thailand Medical Device Industry
Competitive Landscape in Thailand Medical Device Market
Overview of Competition in Thailand Medical Devices Market
Product Heat Map for Major Companies in Thailand Medical Devices Market
Strengths and Weakness of Major Manufacturers in Thailand Medical Devices Market
Market shares for Major Brands present in the Diagnostic Imaging, Hospital Furniture, Dialysis Equipment, Auxiliary Devices and Orthopaedic Products
Cross-Comparison of Major Distributors in Thailand Medical Devices Market
Medical intensive care co. ltd
Thai hospital products co. ltd
Time Period Captured in the Report:
Forecast Period -2021-2026F
By Type of Business Activity
By Type of Medical Consumable
Indoor surgical Gloves and Masks
By Type of Diagnostic Imaging Product
Electro diagnostic apparatus (Functional Examination)
By Type of Cardiac Device
By Type of Respiratory Products
By Type of Hospital Furniture
Hospital Beds with Mechanical Fittings and Dentists' Chairs
Medical, surgical, dental or veterinary furniture
By Type of Auxiliary Product
Artificial body parts (excluding artificial teeth and joints)
By Type of Dental and Orthopedic Products
Artificial teeth and dental fittings
For more information about this report visit https://www.researchandmarkets.com/r/1ra4kp
Investors have lost patience with the slow-paced clinical trials of genetic therapies, and some are using the upbeat news to exit Intellia and peers.
Stéphane Bancel discusses the company’s latest Covid shot and prospects for using mRNA in seasonal flu vaccines and personalized treatments for cancer
Intellia said Friday it knocked out the gene responsible for a rare and deadly swelling disorder. But CRISPR stocks sank.
Long-time Real Money subscribers have come to learn I like to combine investment approaches. No one investment approach (fundamental, technical, quantitative) is perfect and better results can come from blending or combining different methods. The On-Balance-Volume (OBV) line has also moved sideways suggesting a balance between buyers and sellers.
Gilead Sciences Inc (NASDAQ: GILD) announced updates to the World Health Organization's (WHO) Therapeutics and COVID-19: living guideline, which now conditionally recommends Veklury (remdesivir) for severe COVID-19. WHO continues to conditionally recommend Veklury in those with non-severe COVID-19 at the highest risk of hospitalization. The WHO conditional recommendation is mainly driven by the final results of the WHO-sponsored SOLIDARITY study, which showed a statistically significant 17% lowe
AT&T CEO John Stankey has a message to rival T-Mobile: Cut the nonsense when advertising to seniors.
Now-redundant, Ethereum miners are flocking to other proof-of-work (PoW) tokens after the network switched to the proof-of-stake (PoS) consensus mechanism.
FedEx has blown three tires before the peak holiday shipping season, and chatter on the Street is that mighty Amazon may have played a role.
As bad the news was for FedEx, it may be worse news for the U.S. economy --- and an early sign of a recession.
'He has gotten nowhere,' said West's lawyer about his attempts to work through partnership issues
Indian billionaire Gautam Adani is now the world’s second richest person. The only person richer than him now is Tesla chief Elon Musk.
Huntsman Corp is a manufacturer and marketer of chemical products for consumers and industrial customers - assorted polyurethanes, performance products, and adhesives. The trading volume has been active since February and the On-Balance-Volume (OBV) line has been in a downward trend since February telling us that sellers of this company have been more aggressive than buyers. The OBV line is stalled and beginning to weaken.
Though the mining industry has been hit hard in recent years, this gold producer is going strong and continues to grow
Berlin, racing to safeguard its energy supplies before its planned ban on Russian oil imports kicks in later this year, said it would place Rosneft’s German subsidiaries under trusteeship.
FedEx to close offices and cut flights on weak outlook, Southwest and Delta note uptick in business travel, Adobe buys Figma for $20 billion in its largest deal, and other news to start your day.
(Bloomberg) -- Wall Street analysts didn’t mince words in discussing FedEx Corp.’s forecast for the current quarter -- which missed by a landslide -- and its withdrawal of full-year guidance. It’s really bad.Most Read from BloombergGermany Tightens Control Over Industry With Russian Oil GrabAdobe Near Deal for Online Design Startup Figma, Sources SayPutin Acknowledges Xi’s ‘Concerns’ on Ukraine, Showing TensionPatagonia Billionaire Who Gave Up Company Skirts $700 Million Tax HitRay Dalio Does th
From couture fashion, to high-end automobiles, it seems luxury buyers can’t get enough. Here's how you can invest in the luxury goods boom.
In that spirit, let's examine two healthcare stocks that seem to have the tools to provide solid returns over the long term: Eli Lilly (NYSE: LLY) and Teladoc Health (NYSE: TDOC). Eli Lilly seems to excel in both areas. Take one of the company's most recent approvals: Mounjaro, a therapy used to control blood glucose levels in patients with type 2 diabetes.
Drug/biotech companies are likely to see significant advances in innovation in 2023. In the Large-Cap Pharmaceuticals industry, AbbVie (ABBV), Novartis (NVS), Merck (MRK) and AstraZeneca (AZN) are worth retaining in your portfolio.
Warren Buffett's Berkshire Hathaway bought a bunch of stocks during the second quarter. Notable names included Apple (NASDAQ: AAPL), Activision Blizzard (NASDAQ: ATVI), Occidental Petroleum (NYSE: OXY), and Chevron (NYSE: CVX). Buffett seems to be most bullish on Apple and Occidental Petroleum.